Related Experiment Video
Updated: Jul 14, 2026
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
Parkinson disease: managing a complex, progressive disease at all stages
1Center for Neurological Restoration, Cleveland Clinic, OH 44195, USA. girouxm@ccf.org
Cleveland Clinic Journal of Medicine
|May 18, 2007
Summary
Parkinson disease management involves addressing motor and nonmotor symptoms. Levodopa-sparing strategies and new therapies can help manage motor complications and improve quality of life.
Area of Science:
- Neurodegenerative diseases
- Movement disorders
- Neurology
Background:
- Parkinson disease presents with complex motor and nonmotor symptoms.
- Levodopa is the primary treatment but can lead to motor complications over time.
- Managing these complications is crucial for patient quality of life.
Purpose of the Study:
- To review current strategies for managing Parkinson disease.
- To discuss the role of levodopa-sparing approaches.
- To highlight advancements in treating motor and nonmotor symptoms.
Main Methods:
- Literature review of Parkinson disease therapies.
- Analysis of treatment outcomes for motor complications.
- Assessment of nonmotor symptom management strategies.
Main Results:
- Levodopa-sparing strategies may delay or reduce motor complications.
- Emerging medical and surgical options improve motor control in advanced stages.
- Addressing nonmotor symptoms enhances overall quality of life.
Conclusions:
- Comprehensive management of Parkinson disease requires attention to both motor and nonmotor symptoms.
- Optimizing levodopa use and exploring new therapies are key.
- Early recognition and treatment of nonmotor symptoms are vital for long-term well-being.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:25Peritoneal Dialysis III: Nursing Management
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation